For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

Hispanic/Latinx males and those who are non-English proficient are significantly less likely to receive germline genetic evaluation for prostate cancer. Undertesting can impact downstream outcomes, ...

In this video, Mitchell Singstock, MD, discusses results of a retrospective study that evaluated genomic testing rates for ...

The alternative text for this image may have been generated using AI. Fig. 2: Study workflow for the identification of African-relevant prostate cancer (PCa) Potentially Pathogenic Variants (PPVs) and ...

MYGN plans to launch its Prolaris + AI Test this month, combining biomarker data and AI pathology to personalize prostate cancer surveillance.

Majority of men in UK will not be offered routine prostate cancer screening - Black men have double the risk of prostate ...

Dr. Daniel P. Petrylak discussed recent developments in prostate cancer care, emphasizing the importance of genetic testing and personalized treatment. Dr. Daniel P. Petrylak, a professor of Medicine ...

The underlying mechanism of the transformation of a normal cell into a cancerous cell lies in the acquisition of faults in ...